AstraZeneca and The Medicines Company announce global collaboration in acute ischaemic heart disease

AstraZeneca and The Medicines Company announced a global collaboration for their acute ischaemic heart disease compounds. The first part of this collaboration is a US co-promotion for AstraZeneca's or…
Read the full story: Breaking World Pharma News